Nakagomi T, Cuevas L E, Gurgel R G, Elrokhsi S H, Belkhir Y A, Abugalia M, Dove W, Montenegro F M U, Correia J B, Nakagomi O, Cunliffe N A, Hart C A
Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4.
The introduction of a G1P[8] rotavirus vaccine in Recife, Brazil, caused a decrease in rotavirus detection from 27% (March-May, 2006) to 5.0% (March-May, 2007), with all strains becoming G2, against which less protection had been predicted.
在巴西累西腓引入G1P[8]轮状病毒疫苗后,轮状病毒的检出率从2006年3月至5月的27%降至2007年3月至5月的5.0%,所有毒株均变为G2型,而此前预计针对该型的保护作用较小。